Ophthalmology Times: August 2022
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA feedback supports Azura’s Ophthalmic's planned NDA for AZR-MD-001 in MGD
2
Aviceda Therapeutics reports positive phase 2b SIGLEC results for AVD-104 in geographic atrophy
3
Strategic approaches optimize teaching and learning in the clinic
4
Argenx discontinues phase 3 UplighTED trials of efgartigimod SC in thyroid eye disease
5
.png "Optometry Times"){kind=logo}
